Amarin (AMRN) highlighted a new post hoc analysis of aspirin use in REDUCE-IT reinforcing that icosapent ethyl significantly reduced cardiovascular events in high-risk patients. These findings ...
First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial Plasma samples were ...
A post hoc analysis of the phase 3b JUMP trial supports the real-world use of ruxolitinib with anemia supportive care to maintain dosing and clinical outcomes in patients with myelofibrosis, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results